The clinical data confirms this: Very surprisingly, ipamorelin did not release ACTH or cortisol in levels significantly different from those observed following GHRH stimulation. This selectivity makes it the cleanest GHRP available and the ideal complement to Tesamorelins GHRH activity
Association between eating behavior patterns and the therapeutic efficacy of GLP-1 receptor agonists in individuals with type 2 diabetes: A multicenter prospective observational study
Do not trust the product
Participants receiving efpeglenatide more frequently achieved weight loss of 5% or 10%
Summary: Understanding Weight Loss Peptide Mechanisms Peptides for weight loss are studied across several distinct biological pathways, with most research focusing on incretin receptor signalling and metabolic regulation
Beyond their well-established benefits in managing type 2 diabetes mellitus (T2DM) and promoting weight reduction, emerging evidence suggests that GLP-1 RAs may also offer neuroprotective, anti-inflammatory, and cardiovascular protective effects 4,5,6,7